SIGN migraine guideline
This Guidelines summary covers the pharmacological options for migraines, medication overuse headache, preventative treatment, and a treatment pathway
NICE low back pain and sciatica guideline
A practical summary of the updated 2016 NICE guideline on the early management of persistent mechanical non-specific low back pain.
NICE palliative care guideline
This brief summary of NICE’s guideline on prescribing opioids in palliative care includes a care pathway algorithm, dose titration, and routes of delivery.
EULAR/ACR polymyalgia rheumatica guideline
A brief guideline on the management of polymyalgia rheumatica. Includes a useful management algorithm.
NICE headache guideline
This easy-to-read summary of NICE's guideline explores the diagnosis and management of tension, migraine, cluster, and medication overuse headaches.
Educational resources
Pharmacological management of chronic mixed pain in primary care
This management algorithm has been commissioned by Grünenthal Ltd, who also provided funding for its development.
Related Guidelines in Practice articles
-
Breast pain: what’s the diagnosis?
Dr Toni Hazell uses case studies to explore three possible causes of breast pain (mastalgia) and how each condition should be managed in primary care
-
Accurate diagnosis of migraine is crucial to successful treatment
Dr David Watson and Dr Sandeep Sharma provide an overview of the recommendations from the latest SIGN guidance on managing migraine
-
Low back pain: what’s the diagnosis?
Dr Simon Somerville considers some possible causes of low back pain and explains that self-management is key to improved quality of life for patients
-
Pelvic pain in women: what’s the diagnosis?
Dr Neelima Sibal and Dr Pallavi Latthe consider possible causes of pelvic pain in women—is it ectopic pregnancy, endometriosis, pelvic inflammatory disease, or something else?
-
Pain in chronic disease may be neuropathic
Dr João Calinas Correia explains what neuropathic pain is, how and when it should be assessed, and how comorbid conditions affect prescribing choices